Oral β-Alanine Supplementation in Patients With COPD
Launched by HASSELT UNIVERSITY · May 11, 2016
Trial Information
Current as of July 22, 2025
Completed
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • COPD: diagnosis of moderate to very severe COPD according to Global Initiative for Chronic Obstructive Lung Disease (GOLD) guidelines
- • Healthy controls: forced expiratory volume at one second/forced vital capacity (FEV1/FVC) \> 0.7, matched for age and gender
- Exclusion Criteria:
- • The presence of known instable cardiac disease
- • neurological disease and/or musculoskeletal disease that preclude safe participation in an exercise test
- • a history of drugs/alcohol abuse
- • vegetarianism
- • inability to understand the Flemish language.
- COPD-specific exclusion criteria:
- • COPD exacerbation and/or hospitalization in the last 6 weeks
- • participation in pulmonary rehabilitation in the previous 12 months.
About Hasselt University
Hasselt University is a prestigious research institution located in Belgium, renowned for its commitment to advancing scientific knowledge and innovation. With a strong focus on interdisciplinary research, the university actively engages in clinical trials that aim to address pressing health challenges. Leveraging a robust network of collaborations with healthcare professionals, industry partners, and research organizations, Hasselt University strives to translate research findings into practical applications that benefit patient care and public health. The institution is dedicated to maintaining the highest ethical standards and regulatory compliance in all its clinical research endeavors.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Hasselt, , Belgium
Patients applied
Trial Officials
Martijn Spruit, prof. dr.
Principal Investigator
Hasselt University
Jana De Brandt, drs
Study Chair
Hasselt University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials